Showing 6901-6910 of 20899 results for "".
- Moving Toward Opioid-Free Surgery: A New Era in Pain Managementhttps://reachmd.com/news/moving-toward-opioid-free-surgery-a-new-era-in-pain-management/2468749/The opioid crisis continues to present significant challenges in the United States, with over 2.5 million adults diagnosed with opioid use disorder in 2022 and opioids implicated in nearly 76% of overdose deaths. As concerns grow over the risks associated with these medications, the
- FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitishttps://reachmd.com/news/fda-approves-nemluvio-moderate-severe-atopic-dermatitis/2470663/Galderma’s Nemluvio® (nemolizumab) has received FDA approval for moderate-to-severe atopic dermatitis in patients aged 12 and older, offering a novel treatment option targeting IL-31. According to a press release from Galderma, the approval follows results from the phase III ARCADIA trial
- Advancements in Digital Eye Models Revolutionize Cataract Surgeryhttps://reachmd.com/news/advancements-digital-eye-models-revolutionize-cataract-surgery/2468769/EU researchers have developed advanced digital models of the eye, dramatically improving the safety and accuracy of cataract surgeries. These models offer personalized surgical plans, benefiting millions across Europe. <
- Exploring DNA Damage in Age-Related Macular Degeneration: A Step Towards New Treatmentshttps://reachmd.com/news/exploring-dna-damage-age-related-macular-degeneration-step-towards-new-treatments/2468768/Recent research has illuminated the significant role that DNA damage plays in age-related macular degeneration (AMD), potentially paving the way for new therapeutic interventions. What's New The article discusses a groundbr
- Study: Cutaneous Lupus Linked with Elevated Cardiovascular Disease Riskhttps://reachmd.com/news/study-cutaneous-lupus-linked-with-elevated-cardiovascular-disease-risk/2468727/Key Takeaways Cutaneous lupus erythematosus (CLE) patients have a significantly increased risk for atherosclerotic cardiovascular disease (ASCVD) comparable to systemic lupus erythematosus (SLE), but higher than psoriasis. Incident ASCVD rates over three years
- Study Finds Kidney Cancer Risk Even at Low Arsenic Levelshttps://reachmd.com/news/study-finds-kidney-cancer-risk-even-at-low-arsenic-levels/2468753/Emerging research from Texas A&M University suggests that exposure to low levels of arsenic in drinking water may significantly increase the risk of kidney cancer, raising concerns about whether current regulatory standards are sufficient to protect public health. The findings, published in <
- Study Explores Genetic Link Between Depression and Period Painhttps://reachmd.com/news/study-explores-genetic-link-between-depression-and-period-pain/2468750/The complex connection between period pain and depression is better understood thanks to a new study published in Briefings in Bioinformatics. Researchers have identified specific genes associated with depression that may increase the likelihood of menstrual pain by 51%. These findings s
- Enhancing Athletes' Reaction Times with Visual Resistance Traininghttps://reachmd.com/news/enhancing-athletes-reaction-times-visual-resistance-training/2468767/A recent study unveils that visual resistance training, using light manipulation, substantially improves reaction times in professional athletes, enhancing their visuomotor skills.
- Tobacco-Free Generation Could Prevent 1.2 Million Lung Cancer Deaths Worldwide, Study Suggestshttps://reachmd.com/news/tobacco-free-generation-could-prevent-12-million-lung-cancer-deaths-worldwide-study-suggests/2468743/A bold proposal to create a "tobacco-free generation" by banning cigarette and tobacco product sales to individuals born between 2006 and 2010 could prevent an estimated 1.2 million lung cancer deaths over the next 70 years, according to new research published in The Lancet Public Health
- AI Tool Offers New Possibilities for Predicting Barrett’s Esophagus and Esophageal Cancerhttps://reachmd.com/news/ai-tool-offers-new-possibilities-for-predicting-barretts-esophagus-and-esophageal-cancer/2468737/Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that may help identify individuals at risk of Barrett’s esophagus and esophageal cancer. Barrett’s esophagus, a condition caused by gastroesophageal reflux disease (GERD), is a known risk factor for esophageal cancer.